-
-
公开(公告)号：EP4188953A1
公开(公告)日：2023-06-07
申请号：EP20750765.8
申请日：2020-07-28
申请人： ADIENNE S.A.
IPC分类号： C07K16/28 , C07K16/40 , A61P21/00 , A61P29/00 , A61K39/395
-
公开(公告)号：EP3536711A1
公开(公告)日：2019-09-11
申请号：EP19170670.4
申请日：2014-02-19
申请人： ADIENNE S.A.
摘要： The present invention pertains to novel antibodies capable of binding to CD26, as well as to their use as a medicament. Moreover, the present invention provides antibodies for use in treating and/or preventing Graft-versus-Host Disease (GvHD), for use in treating Aplastic Anemia and/or for use in promoting engraftment after haematopoietic stem cell transplantation. Furthermore, the present invention provides pharmaceutical compositions comprising at least one antibody of the present invention, as well as provides a kit of parts.
-
-
5.发明公开
-
公开(公告)号：EP2864359A1
公开(公告)日：2015-04-29
申请号：EP14705767.3
申请日：2014-02-19
申请人： ADIENNE S.A.
CPC分类号： C07K16/2896 , A61K39/3955 , A61K2039/505 , A61K2039/545 , C07K16/40 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/565 , C07K2317/76 , C07K2317/92
摘要： The present invention pertains to novel antibodies capable of binding to CD26, as well as to their use as a medicament. Moreover, the present invention provides antibodies for use in treating and/or preventing Graft-versus-Host Disease (GvHD), for use in treating Aplastic Anemia and/or for use in promoting engraftment after haematopoietic stem cell transplantation. Furthermore, the present invention provides pharmaceutical compositions comprising at least one antibody of the present invention, as well as provides a kit of parts.
摘要翻译： 本发明涉及能够结合CD26的新抗体以及它们作为药物的用途。 此外，本发明提供用于治疗和/或预防移植物抗宿主病（GvHD）的抗体，其用于治疗再生障碍性贫血和/或用于促进造血干细胞移植后的移植。 此外，本发明提供了包含本发明的至少一种抗体的药物组合物，并且提供了一组试剂盒。
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.013 秒)
